Valo CEO David Berry (Flagship Pioneering)
Looking to blend AI and human data, Valo Health scores new financing to test drug discovery platform in oncology, beyond
Companies looking to bring machine learning into drug discovery are a dime a dozen, but Boston-based Valo Health believes its proprietary platform could give it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.